SE0101697D0 - Pharmaceutical combination - Google Patents
Pharmaceutical combinationInfo
- Publication number
- SE0101697D0 SE0101697D0 SE0101697A SE0101697A SE0101697D0 SE 0101697 D0 SE0101697 D0 SE 0101697D0 SE 0101697 A SE0101697 A SE 0101697A SE 0101697 A SE0101697 A SE 0101697A SE 0101697 D0 SE0101697 D0 SE 0101697D0
- Authority
- SE
- Sweden
- Prior art keywords
- androgen
- relates
- erbeta
- optionally
- pharmaceutical product
- Prior art date
Links
- 108010041356 Estrogen Receptor beta Proteins 0.000 abstract 2
- 102000000509 Estrogen Receptor beta Human genes 0.000 abstract 2
- 239000000556 agonist Substances 0.000 abstract 2
- 230000002280 anti-androgenic effect Effects 0.000 abstract 2
- 239000000051 antiandrogen Substances 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 2
- 229940127557 pharmaceutical product Drugs 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 102100029951 Estrogen receptor beta Human genes 0.000 abstract 1
- 101001010910 Homo sapiens Estrogen receptor beta Proteins 0.000 abstract 1
- 206010020880 Hypertrophy Diseases 0.000 abstract 1
- 206010060862 Prostate cancer Diseases 0.000 abstract 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 abstract 1
- 239000003098 androgen Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000002307 prostate Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0101697A SE0101697D0 (sv) | 2001-05-14 | 2001-05-14 | Pharmaceutical combination |
| AU2002302737A AU2002302737A1 (en) | 2001-05-14 | 2002-05-08 | Pharmaceutical combination comprising an anti-androgen and an oestrogen receptor beta agonist |
| EP02730415A EP1395286A2 (en) | 2001-05-14 | 2002-05-08 | Pharmaceutical combination comprising an anti-androgen and an oestrogen receptor beta agonist |
| PCT/GB2002/002125 WO2002092129A2 (en) | 2001-05-14 | 2002-05-08 | Pharmaceutical combination comprising an anti-androgen and an oestrogen receptor beta agonist |
| JP2002589045A JP2004529182A (ja) | 2001-05-14 | 2002-05-08 | 医薬組成物 |
| US10/477,242 US20040204390A1 (en) | 2001-05-14 | 2002-05-08 | Pharmaceutical combination comprising an anti-androgen and an oestrogen receptor beta agonist |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0101697A SE0101697D0 (sv) | 2001-05-14 | 2001-05-14 | Pharmaceutical combination |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE0101697D0 true SE0101697D0 (sv) | 2001-05-14 |
Family
ID=20284106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE0101697A SE0101697D0 (sv) | 2001-05-14 | 2001-05-14 | Pharmaceutical combination |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20040204390A1 (sv) |
| EP (1) | EP1395286A2 (sv) |
| JP (1) | JP2004529182A (sv) |
| AU (1) | AU2002302737A1 (sv) |
| SE (1) | SE0101697D0 (sv) |
| WO (1) | WO2002092129A2 (sv) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0424339D0 (en) * | 2004-11-03 | 2004-12-08 | Astrazeneca Ab | Combination therapy |
| JP2016516005A (ja) * | 2013-02-25 | 2016-06-02 | ノバルティス アーゲー | 新規のアンドロゲンレセプター変異 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4760053A (en) * | 1984-08-02 | 1988-07-26 | Fernand Labrie | Combination therapy for selected sex steroid dependent cancers |
| AU7165798A (en) * | 1997-04-28 | 1998-11-24 | Anticancer, Inc. | Use of genistein and related compounds to treat certain sex hormone related conditions |
| ATE208210T1 (de) * | 1997-08-15 | 2001-11-15 | Cephalon Inc | Kombination von proteintyrosin-kinaseinhibitoren und chemischer kastration zur behandlung von prostatakrebs |
| JP3270030B2 (ja) * | 1999-10-12 | 2002-04-02 | 株式会社ファンケル | 食品組成物 |
| GB2361642A (en) * | 2000-10-24 | 2001-10-31 | Karobio Ab | Estrogen receptor beta (ERbeta) agonists for use in cancer treatment |
-
2001
- 2001-05-14 SE SE0101697A patent/SE0101697D0/sv unknown
-
2002
- 2002-05-08 AU AU2002302737A patent/AU2002302737A1/en not_active Abandoned
- 2002-05-08 JP JP2002589045A patent/JP2004529182A/ja not_active Withdrawn
- 2002-05-08 US US10/477,242 patent/US20040204390A1/en not_active Abandoned
- 2002-05-08 WO PCT/GB2002/002125 patent/WO2002092129A2/en not_active Ceased
- 2002-05-08 EP EP02730415A patent/EP1395286A2/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP1395286A2 (en) | 2004-03-10 |
| US20040204390A1 (en) | 2004-10-14 |
| AU2002302737A1 (en) | 2002-11-25 |
| JP2004529182A (ja) | 2004-09-24 |
| WO2002092129A2 (en) | 2002-11-21 |
| WO2002092129A3 (en) | 2003-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE420083T1 (de) | Harnstoff-derivate als vanilloid-rezeptor- antagonisten für die schmerzbehandlung | |
| WO2001026693A3 (en) | Manufacture of polyglutamate-therapeutic agent conjugates | |
| EP1610751A4 (en) | THERAPEUTIC AGENT / LIGAND CONJUGATE COMPOSITIONS, ITS SYNTHESIS PROCESSES AND ITS APPLICATION | |
| SE0100568D0 (sv) | Compounds | |
| EP1364703A4 (en) | "ACTIVE STRUCTURE, DEVICE FOR ACTIVATING A SUBSTANCE AND METHOD FOR ACTIVATING A SUBSTANCE" | |
| IS2114B (is) | Kínasólínafleiður til að meðhöndla æxli | |
| CY1110521T1 (el) | Υποκατεστημενα ινδολια για τη διαμορφωση της nfkb-ενεργοτητας | |
| BR0107565A (pt) | Formas de dosagem de benzimidazol substituìdo e método de emprego das mesmas | |
| ATE388167T1 (de) | Menschlicher antikörper gegen gangliosid gd3 für die transplantationskomplementarität bestimmente regionund derivate des antikörpers gegen das gangliosid gd3 | |
| DE60133029D1 (de) | Mittel zur prävention oder behandlung von psoriasi | |
| EP1423107A4 (en) | FATTY ALCOHOL DRUG CONJUGATES | |
| CY1109361T1 (el) | Υποκατεστημενες 4-αμινοκυκλοεξανολες | |
| HUP0202253A2 (hu) | Szelektív iGluR5-receptorantagonisták a migrén kezelésére | |
| JO2434B1 (en) | New retinoids to treat emphysema | |
| SE0100566D0 (sv) | Compounds | |
| MXPA03008582A (es) | Agentes y metodos para tratamiento de cancer. | |
| TR200002203T2 (tr) | Lemfotoksin (LT) sentezlenme yolunun inhibitörleri kullanılarak foliküler lemfomaların tedavisi. | |
| TR200402230T4 (tr) | O-ikameli 6-metil-tramadol-türevleri | |
| SE0101697D0 (sv) | Pharmaceutical combination | |
| PT1255538E (pt) | Utilizacao do acido 2-metil-tiazolidin-2,4-dicarboxilico e/ou sais compativeis fisiologicamente para tratamento e/ou prevencao de cancros | |
| DE60226319D1 (de) | Verbindungen die ein an einen vektor gebundenes analgetisches molekül enthalten | |
| PT1406859E (pt) | Derivados substituídos de 4-aminociclo-hexanol | |
| SE0101692D0 (sv) | Compounds | |
| ATE252896T1 (de) | Endokrintherapie für brustkrebs: kombinierte behandlung mit tamoxifen und alkyl-pcdfs | |
| DK1420789T3 (da) | Anvendelse af aktivstoffer med my-opioid-receptoragonistisk virkning og opioid-receptorantagonistisk virkning som kombinationslægemidler til cancerbehandling |